Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.6501
-0.0426-6.15%
Post-market: 0.65570.0056+0.86%19:36 EDT
Volume:4.92M
Turnover:3.24M
Market Cap:180.73M
PE:-1.31
High:0.6954
Open:0.6900
Low:0.6401
Close:0.6927
52wk High:2.55
52wk Low:0.5261
Shares:278.00M
Float Shares:245.00M
Volume Ratio:0.89
T/O Rate:2.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:5.78
PE(LYR):-2.52

Loading ...

Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 12

Humacyte Inc Expected to Post a Loss of 10 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Humacyte Inc Expected to Post a Loss of 10 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Humacyte Updates Financial Calendar, Sets Quarterly Results Webcast and Call

Reuters
·
Aug 07

Humacyte Gets NASDAQ Notice After Shares Trade Below $1 Bid-price Minimum

Reuters
·
Aug 01

Humacyte Price Target Maintained with a $2.00/Share by BTIG

Dow Jones
·
Jul 29

Humacyte Says FDA Accepts IND for First-in-human CTEV CABG Study

Reuters
·
Jul 27

Humacyte Announces FDA Acceptance of Ind for First-in-Human Clinical Study of Ctev for Coronary Artery Bypass Grafting

THOMSON REUTERS
·
Jul 27

Humacyte - to Initiate Phase 2a Ctev Study in Cabg This Quarter

THOMSON REUTERS
·
Jul 27

Humacyte Names Nephrologists Kossmann, Roy-chaudhury as Dialysis Access Advisors

Reuters
·
Jul 14

BTIG Remains a Buy on Humacyte (HUMA)

TIPRANKS
·
Jun 24

Piper Sandler Sticks to Its Hold Rating for Humacyte (HUMA)

TIPRANKS
·
Jun 18

Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Qiagen (QGEN)

TIPRANKS
·
Jun 17

U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower

Reuters
·
Jun 17

Humacyte Inc : TD Cowen Cuts Target Price to $1.25 From $1.5

THOMSON REUTERS
·
Jun 17

Humacyte Price Target Maintained With a $2.00/Share by BTIG

Dow Jones
·
Jun 16

Humacyte says Phase 3 study shows bioengineered ATEV blood vessel beats AV fistula in women on dialysis

Reuters
·
Jun 15

Humacyte - Enters Underwriting Agreement for Underwritten Offering on June 10, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 12

Humacyte Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 11

Humacyte, Inc. : H.c. Wainwright Raises Target Price to $4 From $3

THOMSON REUTERS
·
Jun 11